Global Electroconvulsive Therapy Devices Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

SKU ID : QYR-18490385 | Publishing Date : 10-Jun-2021 | No. of pages : 106

Electroconvulsive Therapy (ECT) is treatment considered most safe and effective for certain psychiatric disorders. ECT is the most common treatment performed for severe or major type of depression. Though mechanism of action for this treatment is not fully known. It is said to be effecting central nervous system components such as hormones, neurotransmitters, neurotropic factors and neuropeptides. The process of generalize seizure is required for both the beneficial and adverse effect of ECT. Many studies have shown reduction of glucose metabolism in anterior and posterior part of brain in study of before and after procedure of ECT. Though this treatment is said to be effective for many psychiatric disorder there are significant controversies related to this procedure. Some study have concluded ECT procedure just marginally more effective that other placebo procedures. This procedure is viewed harmful by general population and mental health professionals. Despite of all the controversies ECT is used by US and is endorsed by the American Psychiatric Association. Professional associations of Canada, Netherlands, Germany, Austria, Denmark and India have professional guidelines to use ECT.
The increasing cases of mental illness due to brain injuries, Bacterial infections causing mental disorders and increasing long term use of substance abuse linked to depression and anxiety is expected to increase the usage of ECT device. Changing life style and increasing exposure to harmful toxins is expected to attribute to the increasing usage of the device.

Market Analysis and Insights: Global Electroconvulsive Therapy Devices Market
In 2020, the global Electroconvulsive Therapy Devices market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Electroconvulsive Therapy Devices Scope and Market Size
The global Electroconvulsive Therapy Devices market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Electroconvulsive Therapy Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Unilateral
Bilateral

Segment by Application
Hospitals
Specialty Clinics
Mental Hospitals
Others

By Company
Mecta
Ectron
I.E. Somatic
St.Jude Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports